At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 60 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This study looks at lung cancer in people who have never smoked. Researchers want to understand what may predict this cancer and what the outcomes are. The study is run by University College London Hospitals in the UK.
Who can take part
- Adults aged 18 or over
- People diagnosed or treated for primary lung cancer at a participating study site, based on scans or tissue tests
Who may not be able to
- People who have ever smoked — this means more than 100 cigarettes or 75g of tobacco in their lifetime
- People who have had a prescription for nicotine replacement therapy
- For new participants, people who cannot give their consent
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 225
- Started
- 2024-09-17
- Last checked
- 2024-12
Plain English Summary
What is this study?
- • Testing a new treatment for lung cancer
- • Clinical study - 225 participants
- • The goal of this observational study is to improve the early detection of lung cancer in adults who have smoked less than 100 tobacco cigarettes ("never-smokers") in the United Kingdom
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with lung cancer
Where?
- • London - University College London Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this observational study is to improve the early detection of lung cancer in adults who have smoked less than 100 tobacco cigarettes ("never-smokers") in the United Kingdom. The main questions it aims to answer are: * To describe characteristics such as demographics, co-morbidities and environmental exposures * To describe participant pathways including presentation mode and symptoms to understand if earlier diagnosis would be possible * To describe participant outcomes such as cancer stage, treatment and mortality * To quantitatively or qualitatively measure modifiable and non-modifiable factors that may be associated with LCINS including environmental measures, blood tests and genomic data. Participants will currently have no change to their usual care.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓All adult participants from age of 18 who are diagnosed or treated with primary lung cancer through radiology or...
Who cannot take part
- ✗Participants who have ever smoked cigarettes or tobacco will be excluded; this is defined as:
- ✗More than 100 cigarettes or 75g tobacco in their lifetime
- ✗Those who have received a prescription for nicotine replacement therapy
- ✗For prospective participants, those who cannot consent will be excluded
See the full criteria
Where Is This Study? (1 UK site)
University College London Hospital
London, United Kingdom
Rajinder Sidhu - Associate Director, Research Governance and Operations
uclh.jro-communications@nhs.net020 3447 9825How to Get in Touch
Neal Navani, PhD
Sponsor contactCONTACT
Sindhu Naidu, MBBS
Sponsor contactCONTACT